Search

Search Constraints

You searched for: Author/Creator Lipsky, Peter

Search Results

2. 251 Type II but not type I interferon signifies clinical response to ustekinumab in patients with systemic lupus erythematosus. (April 2019)

7. Efficacy and safety of ustekinumab, an IL-12 and IL-23 inhibitor, in patients with active systemic lupus erythematosus: results of a multicentre, double-blind, phase 2, randomised, controlled study. Issue 10155 (13th October 2018)

9. GG-09 Comparative analysis of gene expression in lupus-affected tissues reveals common and disparate pathways of inflammation. (31st August 2016)